An Act to create 895.532 and 961.571 (1) (b) 4. of the statutes; Relating to: excepting xylazine testing materials from the definition of drug paraphernalia and civil and criminal liability exemptions for distributing and administering xylazine testing products.
| Date / House | Action | Journal |
|---|---|---|
| 1/12/2024 Asm. | Introduced by Representatives Kitchens, Billings, C. Anderson, Behnke, Conley, Considine, Dittrich, Duchow, Gundrum, Jacobson, Mursau, Myers, Nedweski, Ohnstad, Ortiz-Velez, Palmeri, Rozar, Shankland, Sinicki and Subeck; cosponsored by Senators James, Agard, L. Johnson, Pfaff, Roys and Spreitzer | |
| 1/12/2024 Asm. | Read first time and referred to Committee on Criminal Justice and Public Safety | |
| 2/1/2024 Asm. | Public hearing held | |
| 2/1/2024 Asm. | Representative Steffen added as a coauthor | |
| 2/1/2024 Asm. | Senator Carpenter added as a cosponsor | |
| 2/2/2024 Asm. | Representative Madison added as a coauthor | |
| 2/6/2024 Asm. | Representative Emerson added as a coauthor | |
| 2/8/2024 Asm. | Executive action taken | |
| 2/12/2024 Asm. | Report passage recommended by Committee on Criminal Justice and Public Safety, Ayes 15, Noes 0 | |
| 2/12/2024 Asm. | Referred to committee on Rules | |
| 2/15/2024 Asm. | Placed on calendar 2-20-2024 by Committee on Rules | |
| 2/20/2024 Asm. | Representative Joers added as a coauthor | |
| 2/20/2024 Asm. | Laid on the table | |
| 4/15/2024 Asm. | Failed to pass pursuant to Senate Joint Resolution 1 |
